SGN-30: Interim Phase II data
In an ongoing, open-label, U.S. Phase II trial in 17 evaluable patients, up to three
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
In an ongoing, open-label, U.S. Phase II trial in 17 evaluable patients, up to three